Pharmaceuticals, Biotechnology and Life Sciences
—Fully Integrated LIS Now Available in North America is Based on Industry-Leading LabVantage LIMS Platform and Proven in Use at…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–$AVRO—AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a…
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Regulatory Affairs in Asia” conference has been added to ResearchAndMarkets.com’s offering. The pharmaceutical market in Asia is…
LONDON–(BUSINESS WIRE)–#MultiplexedDiagnosticsMarket–The global multiplexed diagnostics market is poised to grow by USD 9.35 billion during 2020-2024, progressing at a CAGR…
Amunix Pharmaceuticals, a tumor cancer-focused biopharmaceutical company has completed $73 million Series A financing round.
GenomSys has moved two of its teams to the BioPôle in Lausanne, to support the company’s growth and improve its accessibility to the Life Sciences community.
GUILFORD, Conn.–(BUSINESS WIRE)–Bioasis Technologies Inc. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a biopharmaceutical company developing its proprietary xB3™ platform technology…
Enrollment ongoing in Phase 1 dose-escalation trials AMELI-01 in r/r AML patients, BALLI-01 in r/r B-ALL patients and MELANI-01 in…
Cellectis grants additional rights to Servier to develop and commercialize all next generation gene-edited allogeneic CAR T-cell products targeting CD19,…
Provides Full Year 2020 Guidance WILMINGTON, N.C.–(BUSINESS WIRE)–PPD, Inc. (NASDAQ: PPD), a leading global contract research organization, today reported its…